Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.

Autor: Cho WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Saade R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nagarajan P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hudgens C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ledesma D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson K; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ivan D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Campbell M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Esmaeli B; Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Curry JL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Journal of cutaneous pathology [J Cutan Pathol] 2024 May; Vol. 51 (5), pp. 360-367. Date of Electronic Publication: 2024 Jan 10.

Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma.

Autor: Pineda-Reyes J; Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA., Arudra SK; Department of Pathology., Aung PP; Department of Pathology., Nagarajan P; Department of Pathology., Curry JL; Department of Pathology.; Department of Dermatology.; Department of Translational Molecular Pathology., Tetzlaff M; Department of Pathology.; Department of Translational Molecular Pathology.; Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, CA., Prieto VG; Department of Pathology.; Department of Dermatology., Wang WL; Department of Pathology., Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Torres-Cabala CA; Department of Pathology.; Department of Dermatology.; Department of Translational Molecular Pathology.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.

Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T H 1 T-cells.

Autor: Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Seervai RNH; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.; Internal Medicine Residency Program, Providence Portland Medical Center, Portland, Oregon, USA., Mudaliar KM; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA., Ma W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Muhlbauer A; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Solis LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nagarajan P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Speiser J; Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA., Hudgens C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cho WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel A; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pacha O; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tetzlaff MT; Departments of Pathology and Dermatology, Oral Pathology and Dermatopathology Unit, The University of California San Francisco, San Francisco, California, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Journal of cutaneous pathology [J Cutan Pathol] 2023 Jul; Vol. 50 (7), pp. 661-673. Date of Electronic Publication: 2023 May 07.

Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma.

Autor: Seervai RNH; Department of Dermatology, Oregon Health and Science University, Portland.; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas.; Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas., Taylor MM; John P. and Katherine G. McGovern Medical School, The University of Texas Health Science Center, Houston.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston., Rahbar Z; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston., Patel SP; Departments of Melanoma Medical Oncology and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston., Prieto VG; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston., Curry JL; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2024 Jun 01; Vol. 160 (6), pp. 682-685.

When leukaemia masquerades: the hidden syphilis diagnosis.

Autor: Musicante M; Department of Internal Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: mmusican@uthsc.edu., Harrell JM; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kubicki S; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Curry JL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel AB; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. e225.